Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

February 2017 Town Hall Teleconference

Vital Signs logo near handset and word bubble with 3 people in it

Too Loud for Too Long ― Loud Noises Damage Hearing

February 14, 2017 • 2:00 to 3:00 PM (ET)

Get Email Updates

Vital Signs Logo near telephone handset next to word bubble with 3 people in it
Assistance

This teleconference has ended.
If you have any questions regarding the event, contact Tonya Joyner.

Agenda

February 2017 Town Hall Teleconference Agenda
Time (ET) Agenda Item Speaker(s)
2:00 PM Welcome & Introduction

José T. Montero, MD, MHCDS
Director, Office for State, Tribal, Local and Territorial Support, CDC

2:05 PM Vital Signs Overview

John Eichwald, MA
Chief, Child Development and Disability Branch, National Center on Birth Defects and Developmental Disabilities, CDC

2:10 PM Presentations

William Hal Martin, PhD
Co-director, Dangerous Decibels

Brian Fligor, ScD, PASC
Chief audiology officer, Lantos Technologies

2:30 PM Q&A and Discussion José T. Montero, MD, MHCDS
2:55 PM Wrap–up  
3:00 PM End of call  

Speakers' Biographies

Portrait image of Debbie Dowell, MD, MPH; Commander, US Public Health ServiceDebbie Dowell, MD, MPH; Commander, US Public Health Service

Senior Medical Advisor/Chief Medical Officer for the Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention

Debbie Dowell is senior medical advisor and chief medical officer for the Division of Unintentional Injury Prevention in CDC’s National Center for Injury Prevention and Control. She is a commander in the US Public Health Service and was the lead author of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain. She previously led CDC’s Prescription Drug Overdose Team and served as advisor to New York City’s health commissioner. Dr. Dowell completed residency and chief residency in primary care internal medicine at the New York University School of Medicine, where she later joined the faculty as a clinical assistant professor. Dr. Dowell is board certified in internal medicine and practiced medicine at a community health center in New York City. She has conducted research on quality and safety in medical care, the effects of clinical guidelines, and the effectiveness of interventions to prevent opioid overdose, including prescription drug monitoring programs and academic detailing. She received her BA and MD from Columbia University and her MPH from the Johns Hopkins Bloomberg School of Public Health and is a graduate of CDC’s Epidemic Intelligence Service.

Portrait image of Chad Garner, MDChad Garner, MD

Director of the Ohio Automated Rx Reporting System

Chad Garner directs the Ohio Automated Rx Reporting System—the Ohio prescription monitoring program (PMP). He has been employed by the Ohio Board of Pharmacy since 2006, having previously served as the PMP database administrator and the chief technical officer. Dr. Garner has been a member of the Prescription Monitoring Information Exchange working group since 2007, serving on both the executive committee and the technical subcommittee. He has been a member of the steering committee of the National Association of Boards of Pharmacy Prescription Monitoring Program InterConnect since 2011, as well as the Governor’s Cabinet Opiate Action Team in Ohio. Chad received his bachelor of science from Mount Vernon Nazarene University in Mount Vernon, Ohio, in 2004 and his master of science from Boston University in 2016.

Portrait image of Lisa MilletLisa Millet, MHS

Director of the Injury and Violence Prevention Program in the Oregon Public Health Division

Lisa Millet has directed the Injury and Violence Prevention Program (IVPP) in the Oregon Public Health Division since 1998. She oversees a staff of thirteen scientists and program personnel who together run a variety of operations that include public health surveillance, public policy development, program planning and implementation, program evaluation, and technical assistance and training. The Oregon IVPP priorities include excellence in surveillance and data dissemination; reducing prescription drug overdose, suicide, and traumatic brain injury; and preventing bike and pedestrian injury. Ms. Millet also oversees the Oregon Prescription Drug Monitoring Program, the Pre-Hospital Emergency Medical Services data system, the Oregon Trauma Registry, the Oregon Violent Death Reporting System, basic injury and violence surveillance and epidemiology, suicide prevention, senior falls prevention, prescription drug overdose prevention, and a variety of injury and violence prevention initiatives designed to reduce the burden of injury and violence in Oregon. Ms. Millet has a master’s degree in health science.

Example Vital Signs button for display on websites Share on your website
Copy the code from the Social Media for CDC Vital Signs™ page to add a button to your website

TOP